Duckworth DH, Gulig PA (2002) Bacteriophages: potential treatment for bacterial infections.
BioDrugs 16:57–62
Duquette RA, Nuttall TJ (2004) Methicillin-resistant Staphylococcus aureus in dogs and cats: an
emerging problem? J Small Anim Pract 45:591–597
EMEA (1999) Antibiotic resistance in the European union associated with therapeutic use
of veterinary medicines, report and qualitative risk assessment by the Committee for Veteri-
nary Medicinal Products. The European Agency for the Evaluation of Medicinal Products,
Europe
Eng RHK, Padberg FT, Smith SM, Tan EN, Cherubin CE (1991) Bactericidal effects of antibiotics
on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother 35:1824–1828
Epstein BJ, Gums JG, Drlica K (2004) The changing face of antibiotic prescribing: The mutant
selection window. Ann Pharmacother 38:1675–1682
Escaich S (2008) Antivirulence as a new antibacterial approach for chemotherapy. Curr Opin
Chem Biol 12:400–408
FDA/CVM Guidance for Industry (#152): Evaluating the safety of antimicrobial new animal drugs
with regard to their microbiological effects on bacteria of human health concern, dated 10/23/
2003.http://www.fda.gov/cvm/Documents/fguide152.pdf
Forrest A, Nix DE, Ballow CH, Goss TF, Birmingham MC, Schentag JJ (1993) Pharmacodynam-
ics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother
37:1073–1081
Franklin A, Acar J, Anthony F, Gupta R, Nicholls T, Tamura Y, Thompson S, Threlfall EJ, Vose D,
Van Vuuren M, White DG, Wegener HC, Costarrica ML (2001) Antimicrobial resistance:
Harmonisation of national antimicrobial resistance monitoring and surveillance programmes in
animals and in animal-derived food. Rev Sci Tech (Off Int Epizoot) 20:859–870
Gilberta P, Brown MRW (1998) Biofilms and -lactam activity. J Antimicrob Chemother 41:571–572
Gunderson BW, Ross GH, Ibrahim KH, Rotschafer JS (2001) What do we really know about
antibiotic pharmacodynamics. Pharmacotherapy 21(10 pt2):302S–318S
Hanlon GW (2007) Bacteriophages: An appraisal of their role in the treatment of bacterial
infections. Int J Antimicrob Agents 30:118–128
Harrison PF, Lederberg J (1998) Antimicrobial resistance: issues and options workshop report.
National Academy Press, Washington DC, pp 1–11
Harrison JJ, Turner RJ, Ceri H (2005) Persister cells, the biofilm matrix and tolerance to metal
cations in biofilm and planktonic Pseudomonas aeruginosa. Environ Microbiol 7:981–994
Hendriksen RS, Mevius DJ, Schroeter A, Teale C, Jouy E, Butaye P, Franco A, Utinane A, Amado A,
Moreno M, Greko C, Sta ̈rk KDC, Berghold C, Myllyniemi AL, Hoszowski A, Sunde M,
Aarestrup FM (2008a) Occurrence of antimicrobial resistance among bacterial pathogens and
indicator bacteria in pigs in different European countries from year 2002–2004: the ARBAO_II
study. Acta Vet Scand 50:19
Hendriksen RS, Mevius DJ, Schroeter A, Teale C, Meunier D, Butaye P, Franco A, Utinane A,
Amado A, Moreno M, Greko C, Sta ̈rk K, Berghold C, Myllyniemi AL, Wasyl D, Sunde M,
Aarestrup FM (2008b) Prevalence of antimicrobial resistance among bacterial pathogens
isolated from cattle in different European countries: 2002–2004. Acta Vet Scand 50:28
Horswill AR, Nauseef WM (2008) Host interception of bacterial communication signals. Cell Host
Microbe Prev 4:507–509
Ibrahim KH, Hovde LB, Ross G, Gunderson B, Wright DH, Rotschafer JC (2002) Microbiologic
effectiveness of time- or concentration-based dosing strategies in Streptococcus pneumoniae.
Diagn Microbiol Infect Dis 44:265–271
Illambas JM, Potter T, Rycroft AN, Lees P (2009) Pharmacodynamics of tulathromycinin vitro
andin vivoagainst calf pathogens. J Vet Pharmacol Ther 32(Suppl 1):62–63
Jayaraman R (2008) Bacterial persistence: Some new insights into an old phenomenon. J Biosci
33:795–805
Jefferson KK (2004) What drives bacteria to produce a biofilm? FEMS Microbiol Lett 236:163–173
260 M. Martinez and P. Silley